Kender Richard N
SEC insider (Form 3/4/5 filer). CIK 0001381205. Director at Seres Therapeutics, Inc. (MCRB) and 2 other issuers. 5 reported Form 4/5 transactions since Sep 2024; latest on Jul 8, 2026. Located in CAMBRIDGE, MA.
Companies Kender Richard N has filed insider reports for
- Seres Therapeutics, Inc. (MCRB): Director, Officer, See Remarks
- Longeveron Inc. (LGVN): Director
- BICYCLE THERAPEUTICS PLC (BCYC): Director
Kender Richard N
CIK: 0001381205
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (5 total)
- Jul 8, 2026MCRB
Seres Therapeutics, Inc.
AwardDirectStock Option (right to buy)
50K shares- - Mar 4, 2026MCRB
Seres Therapeutics, Inc.
AwardDirectStock Option (right to buy)
150K shares- - Jul 15, 2025LGVN
Longeveron Inc.
AwardDirect17K shares- - Apr 10, 2025MCRB
Seres Therapeutics, Inc.
AwardDirectStock Option (right to buy)
100K shares- - Jan 2, 2025BCYC
BICYCLE THERAPEUTICS PLC
AwardDirect6.3K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jul 8, 2026 |  MCRB Seres Therapeutics, Inc. | Award Stock Option (right to buy) | 50,000 | - | - | Direct |
| Mar 4, 2026 | MCRB Seres Therapeutics, Inc. | Award Stock Option (right to buy) | 150,000 | - | - | Direct |
| Jul 15, 2025 |  LGVN Longeveron Inc. | Award | 17,000 | - | - | Direct |
| Apr 10, 2025 | MCRB Seres Therapeutics, Inc. | Award Stock Option (right to buy) | 100,000 | - | - | Direct |
| Jan 2, 2025 |  BCYC BICYCLE THERAPEUTICS PLC | Award | 6,250 | - | $0 | Direct |
1-5 of 5 transactions